Natco Pharma
Navigation
  • Home
  • Our Business
  • About
    • Mission & Heritage
    • Values
    • Management
    • Facilities
    • News & Announcements
  • Innovation
    • Analytical
    • Generic Research
    • Intellectual Property
    • New Drug Discovery
    • Opportunities
  • Markets
    • India
    • International
  • Investors
    • Financials
      • financials
      • Subsidiary Accounts
    • Stocks
    • Shareholder Information
      • Shareholding Pattern
      • Investor Service Request Form
      • Investor Presentation
      • Statutory Communications
      • Scheme of Amalgamation
      • Unclaimed Dividend
      • Investors Education Protection Fund (IEPF)
      • Buy back 2018
      • Buy back 2023
      • PAPER ADVERTISEMENTS
      • Board Meeting Intimations
      • AGM
      • ANNUAL SECRETARIAL COMPLIANCE CERTIFICATE
      • CREDIT RATINGS
    • Annual Reports
      • Annual Return
      • Impact Assessment Report
    • Corporate Governance & Policies
    • Corporate Governance Certificate
    • IR AND SHAREHOLDER CONTACTS
      • INVESTOR RELATIONS
      • FOR GRIEVANCE REDRESSAL
    • QIP 2017
  • People
    • Meet Our People
    • Careers
  • Responsibility
    • CSR Policy
    • Environment, Health & Safety
      • Attivaram
      • Chemical unit-Mekaguda
      • Chemical Unit-Chennai
    • Certification & Awards
    • Natco Trust
    • Business Responsibility Policies
    • Sustainability Report
  • Contact
    • Locations
    • Contact us
Navigation

Our growth story has only just begun. We endeavour to mitigate risk for investors and encourage transparency in all our dealings

Unclaimed Dividend | Natco Pharma

Dear Shareholders,

As you may be aware, the Ministry of Corporate Affairs (MCA) on May 10, 2012 vide reference no. G.S.R_352(E) notified the Investor Education Protection Fund (Uploading of information regarding unpaid and unclaimed amounts lying with companies) Rules, 2012 (IEPF Rules), which are applicable to your Company.

The objective of the IEPF Rules is to help the shareholders to ascertain status of the unclaimed amounts. In terms of these IEPF Rules, your Company has uploaded the following information in respect of the unclaimed dividends lying with the Company for the following years.

 

Name. Folio No.       Year
   


© 2023 NATCO Pharma Limited. All rights reserved Terms of Use | Privacy Policy | Sitemap

Email
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy